Related Experiment Video
Updated: Nov 28, 2025
07:32
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
Published on: May 6, 2020
12.8K
MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity
M Bollmann1, K Pinno1, L I Ehnold1
1Department of Orthopaedic Surgery, Otto-von-Guericke University, Magdeburg, Germany.
Osteoarthritis and Cartilage
|November 27, 2020
Summary
Shed syndecan-4 (Sdc4) in synovial fluid predicts osteoarthritis severity. Matrix metalloproteinase-9 (MMP-9) sheds Sdc4, reducing chondrocyte response to inflammation.
Area of Science:
- Biochemistry
- Molecular Biology
- Rheumatology
Background:
- Osteoarthritis (OA) involves articular cartilage degradation.
- Syndecan-4 (Sdc4) is implicated in OA and inflammatory conditions.
- Sdc4 shedding mechanisms in OA are poorly understood.
Purpose of the Study:
- Investigate Sdc4 shedding regulation in OA.
- Elucidate the mechanisms of Sdc4 shedding in OA.
- Determine the role of Sdc4 shedding in OA pathogenesis.
Main Methods:
- Analysis of articular cartilage, synovial fluid, and membrane from OA patients.
- Quantification of Sdc4, MMP-2, and MMP-9 using ELISA, RT-qPCR, and IHC.
- Evaluation of MMP inhibitors and siRNA on Sdc4 shedding and IL-1 signaling.
Main Results:
- Shed Sdc4 elevated in OA synovial fluid, predicting severity (AUC=0.72).
- MMP-9 levels increased in OA tissues and synovial fluid, correlating with shed Sdc4.
- MMP-9 inhibition/knockdown reduced Sdc4 shedding and chondrocyte IL-1 signaling.
Conclusions:
- Shed Sdc4 is a potential prognostic biomarker for OA cartilage degradation.
- MMP-9 acts as the primary sheddase for Sdc4 in OA.
- Sdc4 shedding desensitizes chondrocytes to IL-1 signaling, impacting OA progression.
